3,107
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication

, , , , , , , & ORCID Icon show all
Pages 712-721 | Received 20 Jan 2017, Accepted 10 Mar 2017, Published online: 07 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Changqing Yu, Guosheng Wang, Qiang Liu, Jingbo Zhai, Mengzhou Xue, Qiang Li, Yuanhua Xian & Chunfu Zheng. (2023) Host antiviral factors hijack furin to block SARS-CoV-2, ebola virus, and HIV-1 glycoproteins cleavage. Emerging Microbes & Infections 12:1.
Read now
Alessandro Sinigaglia, Elektra Peta, Silvia Riccetti & Luisa Barzon. (2020) New avenues for therapeutic discovery against West Nile virus. Expert Opinion on Drug Discovery 15:3, pages 333-348.
Read now

Articles from other publishers (31)

Junyao Xiong, Mengxue Yan, Shuo Zhu, Bohan Zheng, Ning Wei, Lingen Yang, Youhui Si, Shengbo Cao & Jing Ye. (2022) Increased Cleavage of Japanese Encephalitis Virus prM Protein Promotes Viral Replication but Attenuates Virulence. Microbiology Spectrum 10:3.
Crossref
Mark Damen, Mario Izidoro, Debora Okamoto, Lilian Oliveira, Helene Amatdjais-Groenen, Stijn van Dongen, Koen van Cleef, Ronald van Rij, Cindy Dieteren, Daniel Gironés, Bernd van Buuren, Byron Martina, Albert Osterhaus, Luiz Juliano, Bob Scholte & Martin Feiters. (2022) Cationic Geminoid Peptide Amphiphiles Inhibit DENV2 Protease, Furin, and Viral Replication. Molecules 27:10, pages 3217.
Crossref
Simon Huber, Niklas J. Braun, Luna C. Schmacke, Jun Ping Quek, Robin Murra, Daniela Bender, Eberhard Hildt, Dahai Luo, Andreas Heine & Torsten Steinmetzer. (2022) Structure-Based Optimization and Characterization of Macrocyclic Zika Virus NS2B-NS3 Protease Inhibitors. Journal of Medicinal Chemistry 65:9, pages 6555-6572.
Crossref
Abdul Wahaab, Bahar E Mustafa, Muddassar Hameed, Nigel J. Stevenson, Muhammad Naveed Anwar, Ke Liu, Jianchao Wei, Yafeng Qiu & Zhiyong Ma. (2021) Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review. Viruses 14:1, pages 44.
Crossref
Barbara Schroeder, Peter Demirel, Christina Fischer, Enaam Masri, Stephanie Kallis, Lisa Redl, Thomas Rudolf, Silke Bergemann, Christoph Arkona, Christoph Nitsche, Ralf Bartenschlager & Jörg Rademann. (2021) Nanoparticular Inhibitors of Flavivirus Proteases from Zika, West Nile and Dengue Virus Are Cell-Permeable Antivirals. ACS Medicinal Chemistry Letters 12:12, pages 1955-1961.
Crossref
Saan Voss & Christoph Nitsche. (2021) Targeting the protease of West Nile virus. RSC Medicinal Chemistry 12:8, pages 1262-1272.
Crossref
Thuy Van Lam van, Miriam Ruth Heindl, Christine Schlutt, Eva Böttcher-Friebertshäuser, Ralf Bartenschlager, Gerhard Klebe, Hans Brandstetter, Sven O. Dahms & Torsten Steinmetzer. (2021) The Basicity Makes the Difference: Improved Canavanine-Derived Inhibitors of the Proprotein Convertase Furin. ACS Medicinal Chemistry Letters 12:3, pages 426-432.
Crossref
I. Olaposi Omotuyi, Oyekanmi Nash, Basiru O. Ajiboye, Victor O. Olumekun, Babatunji E. Oyinloye, Oludare T. Osuntokun, Adebisi Olonisakin, A. Olajide Ajayi, Olasehinde Olusanya, Funmilola S. Akomolafe & Niyi Adelakun. (2020) Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS‐CoV ‐2 drug targets: in vitro validation of furin inhibition . Phytotherapy Research 35:2, pages 908-919.
Crossref
Suriyea Tanbin, Fazia Adyani Ahmad Fuad & Azzmer Azzar Abdul Hamid. (2020) Virtual Screening for Potential Inhibitors of Human Hexokinase II for the Development of Anti-Dengue Therapeutics. BioTech 10:1, pages 1.
Crossref
Adib Afandi Abdullah, Yean Kee Lee, Sek Peng Chin, See Khai Lim, Vannajan Sanghiran Lee, Rozana Othman, Shatrah Othman, Noorsaadah Abdul Rahman, Rohana Yusof & Choon Han Heh. (2020) Discovery of Dengue Virus Inhibitors. Current Medicinal Chemistry 27:30, pages 4945-5036.
Crossref
Niklas J. Braun, Jun P. Quek, Simon Huber, Jenny Kouretova, Dorothee Rogge, Heike Lang‐Henkel, Ezekiel Z. K. Cheong, Bing L. A. Chew, Andreas Heine, Dahai Luo & Torsten Steinmetzer. (2020) Structure‐Based Macrocyclization of Substrate Analogue NS2B‐NS3 Protease Inhibitors of Zika, West Nile and Dengue viruses. ChemMedChem 15:15, pages 1439-1452.
Crossref
Berit Troost & Jolanda M Smit. (2020) Recent advances in antiviral drug development towards dengue virus. Current Opinion in Virology 43, pages 9-21.
Crossref
Shovonlal Bhowmick, Siham A. Alissa, Saikh Mohammad Wabaidur, Rupesh V. Chikhale & Md Ataul Islam. (2020) Structure‐guided screening of chemical database to identify NS3‐NS2B inhibitors for effective therapeutic application in dengue infection. Journal of Molecular Recognition 33:7.
Crossref
Natália Salomão, Kíssila Rabelo, Carlos Basílio-de-Oliveira, Rodrigo Basílio-de-Oliveira, Luiz Geraldo, Flávia Lima, Flávia dos Santos, Gerard Nuovo, Edson R. A. Oliveira & Marciano Paes. (2020) Fatal Dengue Cases Reveal Brain Injury and Viral Replication in Brain-Resident Cells Associated with the Local Production of Pro-Inflammatory Mediators. Viruses 12:6, pages 603.
Crossref
Saan Voss & Christoph Nitsche. (2020) Inhibitors of the Zika virus protease NS2B-NS3. Bioorganic & Medicinal Chemistry Letters 30:5, pages 126965.
Crossref
Wioletta Rut, Katarzyna Groborz, Linlin Zhang, Sylwia Modrzycka, Marcin Poreba, Rolf Hilgenfeld & Marcin Drag. (2020) Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses. Antiviral Research 175, pages 104731.
Crossref
Conrrad M.R. Nicholls, Madhumati Sevvana & Richard J. Kuhn. 2020. Virus Assembly and Exit Pathways. Virus Assembly and Exit Pathways 33 83 .
Gonzalo Izaguirre. (2019) The Proteolytic Regulation of Virus Cell Entry by Furin and Other Proprotein Convertases. Viruses 11:9, pages 837.
Crossref
Edeildo Ferreira da Silva-Júnior & João Xavier de Araújo-Júnior. (2019) Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses. Bioorganic & Medicinal Chemistry 27:18, pages 3963-3978.
Crossref
Foysal Ahammad, Tengku Rogayah Tengku Abd Rashid, Maizan Mohamed, Suriyea Tanbin & Fazia Adyani Ahmad Fuad. (2019) Contemporary Strategies and Current Trends in Designing Antiviral Drugs against Dengue Fever via Targeting Host-Based Approaches. Microorganisms 7:9, pages 296.
Crossref
Thuy Van Lam van, Teodora Ivanova, Kornelia Hardes, Miriam Ruth Heindl, Rory E. Morty, Eva Böttcher‐Friebertshäuser, Iris Lindberg, Manuel E. Than, Sven O. Dahms & Torsten Steinmetzer. (2019) Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin. ChemMedChem 14:6, pages 673-685.
Crossref
Ankur Kumar, Brooke Liang, Murali Aarthy, Sanjeev Kumar Singh, Neha Garg, Indira U. Mysorekar & Rajanish Giri. (2018) Hydroxychloroquine Inhibits Zika Virus NS2B-NS3 Protease. ACS Omega 3:12, pages 18132-18141.
Crossref
Wint Wint Phoo, Zhenzhen Zhang, Melissa Wirawan, Edwin Jun Chen Chew, Alvin Bing Liang Chew, Jenny Kouretova, Torsten Steinmetzer & Dahai Luo. (2018) Structures of Zika virus NS2B-NS3 protease in complex with peptidomimetic inhibitors. Antiviral Research 160, pages 17-24.
Crossref
Vahid Dianati, Anna Kwiatkowska, Frédéric Couture, Roxane Desjardins, Yves L. Dory & Robert Day. (2018) Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines. Journal of Medicinal Chemistry 61:18, pages 8457-8467.
Crossref
Anastasia A. Martinez, Bianca A. Espinosa, Rebecca N. Adamek, Brent A. Thomas, Jennifer Chau, Edwardo Gonzalez, Niroshika Keppetipola & Nicholas T. Salzameda. (2018) Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor. European Journal of Medicinal Chemistry 157, pages 1202-1213.
Crossref
Yu-Shi Tian, Yi Zhou, Tatsuya Takagi, Masanori Kameoka & Norihito Kawashita. (2018) Dengue Virus and Its Inhibitors: A Brief Review. Chemical and Pharmaceutical Bulletin 66:3, pages 191-206.
Crossref
Wolfgang Garten. 2018. Activation of Viruses by Host Proteases. Activation of Viruses by Host Proteases 205 248 .
Torsten Steinmetzer & Kornelia Hardes. 2018. Activation of Viruses by Host Proteases. Activation of Viruses by Host Proteases 279 325 .
Teodora Ivanova, Kornelia Hardes, Stephanie Kallis, Sven O. Dahms, Manuel E. Than, Sebastian Künzel, Eva Böttcher-Friebertshäuser, Iris Lindberg, Guan-Sheng Jiao, Ralf Bartenschlager & Torsten Steinmetzer. (2017) Optimization of Substrate-Analogue Furin Inhibitors. ChemMedChem 12:23, pages 1953-1968.
Crossref
CongBao Kang, Thomas H. Keller & Dahai Luo. (2017) Zika Virus Protease: An Antiviral Drug Target. Trends in Microbiology 25:10, pages 797-808.
Crossref
Tobias Schöne, Lena Lisbeth Grimm, Naoki Sakai, Linlin Zhang, Rolf Hilgenfeld & Thomas Peters. (2017) STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease. Antiviral Research 146, pages 174-183.
Crossref